Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

K16 can partially replace K14 but causes hair loss and skin issues.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Finasteride effectively treats hair loss in transgender men with few side effects.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

More research is needed to improve lower body gender affirmation techniques.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Long-COVID has diverse, long-term health impacts, especially in young people.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Finasteride is safe and effective for hair loss in transgender men, but may affect testosterone therapy.

Gender and social factors, not just biology, affect COVID-19 death rates.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

New research shows that skin diversity is influenced by different types of dermal fibroblasts and their development, especially involving the Wnt/β-catenin pathway.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Dermatology residency programs need better DEI training to improve care for diverse patients.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.